The first oral pill to treat postpartum depression is expected to be available in December — and cost nearly $16,000 without insurance About one in seven new mothers experience postpartum ...

Approved by the FDA in August, Zurzuvae is an oral pill that a mother experiencing postpartum depression can take at any point after giving birth to treat their symptoms.

The pill, to be taken daily for at least two weeks, significantly reduced postpartum depression among new mothers in a recent trial.

A first-of-its-kind pill for postpartum depression had promising results in recent trials, and could be approved as soon as next week. Zuranolone is now being evaluated by the Food and Drug ...

A new ketamine pill may help hard-to-treat depression with fewer side effects than other forms of the treatment, early research suggests.

Ketamine pills for depression show positive results in trial—but with caveats A slow-release oral dose showed good safety, but efficacy is shaky.